ena-STUDY-CANCER RESEARCH UK CAMBRIDGE INSTITUTE-06-05-2015-05:50:30:332-141
Non-invasive molecular monitoring of tumour burden and clonal selection in response to targeted therapy.
Targeted sequencing of circulating tumor DNA in patients with NSCLC
Targeted sequencing of circulating tumor DNA in patients with NSCLC